{"id":"W2140051179","doi":"10.1191/1352458505ms1205oa","title":"Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis","year":2005,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society","keywords":"Natalizumab; Multiple sclerosis; Medicine; Internal medicine; Placebo; Lesion; Gastroenterology; Clinical trial; Phases of clinical research; Surgery; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002453632,0.0004972933,0.001368036,0.001378997,0.0005655422,0.00009640423,0.0003272846,0.0002751542,0.0001739462],"category_scores_gemma":[0.006677864,0.0004371058,0.0003270006,0.001031302,0.0004278955,0.0006666864,0.0004426165,0.001403388,0.00001419541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005691969,"about_ca_system_score_gemma":0.0003020602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000658935,"about_ca_topic_score_gemma":0.004698316,"domain_scores_codex":[0.9946982,0.0004290825,0.002013566,0.0006771031,0.001098286,0.0010838],"domain_scores_gemma":[0.9968703,0.001179951,0.0005095077,0.000512175,0.0003558859,0.0005721214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.05028253,0.008009082,0.08599086,0.0001933714,0.0002216209,0.00006130771,0.00585136,0.0002524699,0.6272667,0.00001037861,0.0009008749,0.2209595],"study_design_scores_gemma":[0.4462753,0.005048449,0.4497334,0.004619561,0.0001044913,0.0001025428,0.002371089,0.01578499,0.07428347,0.00002185808,0.000974165,0.0006807204],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939746,0.002109121,0.0001075335,0.001820569,0.0002441801,0.001509798,0.00006328966,0.00004500525,0.0001258642],"genre_scores_gemma":[0.9853756,0.008232263,0.005455896,0.0001236812,0.0004797002,0.0001483329,0.00001599825,0.00007207495,0.00009640771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5529832,"threshold_uncertainty_score":0.9998081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1414482400217475,"score_gpt":0.348538242617605,"score_spread":0.2070900025958576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}